- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
TTY Biopharm Co Ltd (4105)
TTY Biopharm Co Ltd stock price live, this page displays TWO 4105 stock exchange data. View the 4105 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the TTY Biopharm Co Ltd real time stock price chart below.
What Is the TTY Biopharm Co Ltd Stock Price Today?
The TTY Biopharm Co Ltd stock price today is 76.50.
What Is the Stock Symbol for TTY Biopharm Co Ltd?
The stock symbol for TTY Biopharm Co Ltd is ""4105.""
What Stock Exchange Does TTY Biopharm Co Ltd Trade On?
TTY Biopharm Co Ltd is listed and trades on the TPEX stock exchange.
Is TTY Biopharm Co Ltd a Good Stock to Buy?
Determining whether TTY Biopharm Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4105 quote. (ISIN: TW0004105002)
What Is the TTY Biopharm Co Ltd Stock Price Today?
The TTY Biopharm Co Ltd stock price today is 76.50.
What Is the Stock Symbol for TTY Biopharm Co Ltd?
The stock symbol for TTY Biopharm Co Ltd is ""4105.""
What Stock Exchange Does TTY Biopharm Co Ltd Trade On?
TTY Biopharm Co Ltd is listed and trades on the TPEX stock exchange.
Is TTY Biopharm Co Ltd a Good Stock to Buy?
Determining whether TTY Biopharm Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4105 quote. (ISIN: TW0004105002)
TPEX
Currency in TWD
76.50
-0.90(-1.16%)
Closed·
Fair Value
An estimate of a TTY Biopharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
76.50
77.40
52 wk Range
66.20
80.90
4105 Scorecard
Full Analysis
High shareholder yield
High dividend Yield
1/2
Fair Value
An estimate of a TTY Biopharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
76.5077.40
52 wk Range
66.2080.90
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.56%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.56%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4105 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a TTY Biopharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
81.00
Upside
+5.88%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 3 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
TTY Biopharm Co Ltd Company Profile
TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally. The company operates through Oncology Business Unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business Unit, and Other Business Unit segments. It offers oncology drugs under the Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, and Pemazyre names for anti-cancer and supplementary treatments. The company provides anti-infection drugs under the Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax names for anti-infection and flu. In addition, it offers healthcare related drugs under the Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin names for digest system, osteoporosis, and metabolism. Further, the company engages in the selling functional foods; and import and export trading and investment activities. The company was incorporated in 1960 and is headquartered in Taipei, Taiwan.
Compare 4105 to Peers and Sector
Metrics to compare | 4105 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4105PeersSector | |
|---|---|---|---|---|
P/E Ratio | 12.2x | 20.7x | −0.5x | |
PEG Ratio | 0.30 | −0.95 | 0.00 | |
Price/Book | 3.1x | 4.4x | 2.6x | |
Price / LTM Sales | 3.1x | 4.0x | 3.3x | |
Upside (Analyst Target) | 4.7% | 0.7% | 43.5% | |
Fair Value Upside | Unlock | 21.5% | 6.9% | Unlock |
Analyst Ratings
0 Buy
2 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 81.00
(+5.88% Upside)
Earnings
Latest Release
Aug 05, 2025
EPS / Forecast
1.08 / 1.08
Revenue / Forecast
1.48B / 1.40B
FAQ
What Stock Exchange Does TTY Biopharm Trade On?
TTY Biopharm is listed and trades on the Taipei Exchange stock exchange.
What Is the Stock Symbol for TTY Biopharm?
The stock symbol for TTY Biopharm is "4105."
What Is the TTY Biopharm Market Cap?
As of today, TTY Biopharm market cap is 19.25B.
What Is TTY Biopharm's Earnings Per Share (TTM)?
The TTY Biopharm EPS (TTM) is 6.37.
When Is the Next TTY Biopharm Earnings Date?
TTY Biopharm will release its next earnings report on 30 Oct 2025.
From a Technical Analysis Perspective, Is 4105 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has TTY Biopharm Stock Split?
TTY Biopharm has split 13 times.
How Many Employees Does TTY Biopharm Have?
TTY Biopharm has 342 employees.
What is the current trading status of TTY Biopharm (4105)?
As of 07 Aug 2025, TTY Biopharm (4105) is trading at a price of 76.50, with a previous close of 72.80. The stock has fluctuated within a day range of 76.50 to 77.40, while its 52-week range spans from 66.20 to 80.90.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.